Non-Invasive Cancer Diagnostics Market
According to Intent Market Research, the Non-Invasive Cancer Diagnostics Market is expected to grow from USD 5.3 billion in 2024-e at a CAGR of 10.3% to touch USD 9.6 billion by 2030. The Non-Invasive Cancer Diagnostics Market is dominated by key players such as, Roche Diagnostics, Guardant Health, Illumina, Foundation Medicine, and Siemens Healthineers.